Softec HD; Softec I; Softec HDO; Softec HDM
Lenstec, Inc. · Decision date Dec 4, 2025
What did the FDA approve?
FDA records P090022/S047 as a supplement to PMA P090022, with the supplement type “Normal 180 Day Track”. The recorded decision is approval, dated Dec 4, 2025.
FDA approval order statement
approval for a different material vial stopper from an alternate supplier.
- Regulatory pathway
- PMA supplement
- Supplement type
- Normal 180 Day Track
- Clinical specialty
- Ophthalmic
- Decision date
- Dec 4, 2025
- FDA change category
- Change Design/Components/Specifications/Material
Regulatory record facts
- Identifier
- P090022/S047
- Regulatory pathway
- PMA supplement
- Applicant
- Lenstec, Inc.
- Product code
- HQL
- Decision code
- APPR
- Decision date
- Dec 4, 2025
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: intraocular lens.
- Applicant
- Lenstec, Inc.
- Product code
- HQL
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
P090022/S046 · Related supplement
Softec HD; Softec I; Softec HD PS; Softec HDO; Softec HDM
P090022/S047 received
Application receipt date recorded by FDA.
P090022/S047 · FDA decision
Normal 180 Day Track
P090022/S049 · Related supplement
Softec HD; Softec I; Softec HD PS; Softec HDO; Softec HDM
Timeline entries are records held by MedtechLedger for P090022. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P090022
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Lenstec, Inc. | PMA supplement | Aug 12, 2025 | FDA | |
| Lenstec, Inc. | PMA supplement | Apr 15, 2026 | FDA |
Explore the linked device profile
Other records with product code HQL
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
FINEVISION HP Trifocal IOLsP240038/S004 | Beaver-Visitec International, Inc. | PMA supplement | Oct 27, 2026 | FDA |
CT LUCIA Intraocular Lenses (IOLs)P100016/S028 | Carl Zeiss Meditec Production, LLC | PMA supplement | Oct 23, 2026 | FDA |
enVista Hydrophobic Acrylic Intraocular LensP910056/S067 | Bausch + Lomb, Inc. | PMA supplement | Oct 23, 2026 | FDA |
| Johnson & Johnson Surgical Vision, Inc. | PMA supplement | Oct 19, 2026 | FDA | |
| Johnson & Johnson Surgical Vision, Inc. | PMA supplement | Oct 19, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Lenstec, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 1765 Commerce Ave. N, St. Petersburg, FL, 33716
Sources and methodology
- Original FDA record: P090022/S047
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records



